What on earth is going on with the Diageo share price in 2025?

With Diageo’s share price getting off to a poor start in 2025, this Fool wonders if now’s the time for him to throw in the towel on this FTSE 100 stock.

| More on:
Frustrated young white male looking disconsolate while sat on his sofa holding a beer

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The Diageo (LSE: DGE) share price has started 2025 the way it ended 2024 (and 2022 and 2023). Down!

Admittedly, we’re only two weeks into the New Year, but it’s not a great start. Shares of the premium spirits powerhouse are down 5%. With the FTSE 100 index off to a flyer this year, up nearly 4% already and just hitting a fresh record, Diageo shareholders like myself are left frustrated once again.

What’s going on here? And should I ring the bell and announce closing time on this stock? Let’s take a look.

Drip-drip of downbeat developments

There hasn’t been any single update that has sent the stock lower. Instead, there has been a steady stream of negative news and nothing good to counter it.

Last week, for example, we learned why fund manager Terry Smith dumped Diageo shares last year. He lost faith in the new management team after the build-up of unsold booze in Latin America, while also fearing GLP-1 weight-loss drugs like Wegovy were about to negatively impact the drinks industry.

We suspect the entire drinks sector is in the early stages of being impacted negatively by weight-loss drugs. Indeed, it seems likely that the drugs will eventually be used to treat alcoholism such is their effect on consumption.

Terry Smith, Fundsmith Equity Fund annual letter to shareholders, 2024

However, Fundsmith’s sale was back in the summer and the market has known about the lurking GLP-1 drugs issue for a while. So these are unlikely to be the sole reasons for the stock’s weakness this year.

Another negative development was that India’s federal investigating agency has alleged that Diageo made suspicious payments to a politician’s firm in order to attain favourable government decisions. We don’t know when this allegedly happened and Diageo said it’s cooperating with the agency. India is massive and likely to be an important growth market for it over the long term, so this news wasn’t welcome.

Earlier this month, US Surgeon General Vivek Murthy called for alcoholic drinks to carry cancer warning labels like cigarettes. It’s unclear whether this will be implemented, but some analysts fear alcohol firms might be heading the way of tobacco stocks — slow growth, declining customer base, higher regulation, and lower valuations.

Finally, there’s the looming threat of soon-to-be- President Trump’s tariffs, which could take a bite out of Diageo’s profits. It exports a load of Canadian whisky and Mexican tequila into America each year. So it’s in the firing line.

Should I throw in the towel?

The stock looks decent value, trading at 16.5 times forecast earnings for FY26 (starting July). The forward dividend yield is now approaching 4%, so perhaps there’s something in the tobacco stock comparisons. They’re bought primarily for the income rather than any expectations of long-term industry growth.

Diageo is due to report H1 2025 results in February, and one of my biggest fears is hearing management utter those dreaded words: GLP-1. If it says these are indeed having an impact, the stock would likely be crushed.

Still, I’m keeping hold of my shares and hoping for green shoots of recovery in the global drinks market, or at least something to be optimistic about. I get enough doom and gloom from the news — I don’t need any more in my portfolio!

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ben McPoland has positions in Diageo Plc. The Motley Fool UK has recommended Diageo Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

2 UK shares that could soar if interest rates sprint lower!

The Bank of England's latest meeting has fed speculation of swingeing interest rate cuts. I think these UK shares could…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

My favourite FTSE dividend stock just jumped 17%! So why am I sad?

This investor has mixed feelings today as a quality dividend stock from the FTSE 250 surged higher in his portfolio.…

Read more »

Investing Articles

Here’s why AstraZeneca stock jumped nearly 6% in the FTSE 100 today

FTSE 100 heavyweight AstraZeneca helped propel the blue-chip index to a record high today. Here's what investors were cheering.

Read more »

Closeup of "interest rates" text in a newspaper
Investing Articles

Interest rates fall again! Here are 3 FTSE dividend growth shares to consider buying

As interest on cash savings becomes increasingly less attractive, Paul Summers has been looking at dividend growth shares for passive…

Read more »

Investing Articles

Up 10% today, I think this FTSE 250 growth share could continue to surge!

Babcock International's flying after upgrading its full-year forecasts. I think the FTSE 250 defence share might just be getting started.

Read more »

Investing Articles

The AstraZeneca share price jumps 5% on today’s strong results – but is it too expensive?

Harvey Jones hails the brilliant long-term performance of the AstraZeneca share price, but wonders whether the FTSE 100's biggest company…

Read more »

Investing Articles

Is this my chance to buy Alphabet shares?

A big step up in AI spending at Google has investors nervous, but has it created an opportunity to buy…

Read more »

Senior woman potting plant in garden at home
Investing Articles

£10k in savings? Here’s how an investor could aim for a monthly second income of £1,200

Mark David Hartley considers how investors could build towards an early retirement plan with a second income from a portfolio…

Read more »